27.38USD+4.03%Mkt Cap: 1.89B $P/E: —1d ago
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap1.89B $
Enterprise Value1.83B $
Revenue (TTM)751.00K $
Gross Profit-189.00K $
Net Income (TTM)-72.78M $
Revenue/Share0.0110 USD
Last Price27.38 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS74587B1017
Valuation
P/E (Trailing)—
P/E (Forward)-25.12
PEG—
EV/EBITDA-24.00
EV/Revenue2441.81
P/S2523.25
P/B28.17
EPS (TTM)-1.10
EPS (Forward)-1.09
52W Range
12.5680% of range31.00
52W High31.00 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-4775.56%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.12M $
CapEx (TTM)335.00K $
FCF Margin-3872.19%
FCF Yield-1.53%
Net Debt-61.16M $
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity0.09
Current Ratio7.26
Quick Ratio6.99
Book Value/Sh0.9720 USD
Cash/Share0.9870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)30.67 USD
Upside (mean)+12.0%
Target Range30.00 USD – 32.00 USD
$30.00+12.0% to mean$32.00
# Analysts3
Ownership
Shares Out.69.21M
Float18.48M
Insiders73.21%
Institutions11.59%
Short Interest
Short Ratio7.5d
Short % Float14.86%
Short % Out.4.13%
Shares Short2.86M
Short (prev mo.)3.09M
Technical
SMA 5025.25 (+8.4%)
SMA 20019.57 (+39.9%)
Beta1.65
S&P 52W Chg20.25%
Avg Vol (30d)329.69K
Avg Vol (10d)251.38K
Technical Indicators
RSI (14)54.1
MACD0.3871
MACD Signal0.6547
MACD Hist.-0.2675
BB Upper29.79 USD
BB Middle26.98 USD
BB Lower24.17 USD
BB Width20.82%
ATR (14)1.713 USD
Vol Ratio (20d)0.53x